220 related articles for article (PubMed ID: 34607367)
21. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
[TBL] [Abstract][Full Text] [Related]
22. Degree of thyrotropin suppression in differentiated thyroid cancer without recurrence or metastases.
Kamel N; Güllü S; Dağci Ilgin S; Corapçioğlu D; Tonyukuk Cesur V; Uysal AR; Başkal N; Erdoğan G
Thyroid; 1999 Dec; 9(12):1245-8. PubMed ID: 10646665
[TBL] [Abstract][Full Text] [Related]
23. Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
Gazdag A; Nagy EV; Erdei A; Bodor M; Berta E; Szabó Z; Jenei Z
J Endocrinol Invest; 2015 Feb; 38(2):133-42. PubMed ID: 25194423
[TBL] [Abstract][Full Text] [Related]
24. [Potential risks of the adverse effects of thyrotropin suppression in differentiated thyroid carcinoma].
Reverter JL; Colomé E
Endocrinol Nutr; 2011 Feb; 58(2):75-83. PubMed ID: 21247815
[TBL] [Abstract][Full Text] [Related]
25. LEVOTHYROXINE REPLACEMENT IN OBESE HYPOTHYROID FEMALES AFTER TOTAL THYROIDECTOMY.
Glymph K; Gosmanov AR
Endocr Pract; 2016 Jan; 22(1):22-9. PubMed ID: 26437220
[TBL] [Abstract][Full Text] [Related]
26. Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine.
Laugesen E; Moser E; Sikjaer T; Poulsen PL; Rejnmark L
Thyroid; 2016 Jun; 26(6):779-84. PubMed ID: 27029953
[TBL] [Abstract][Full Text] [Related]
27. Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer.
Schumm MA; Lechner MG; Shu ML; Ochoa JE; Kim J; Tseng CH; Leung AM; Yeh MW
Endocr Pract; 2021 Jul; 27(7):691-697. PubMed ID: 33642257
[TBL] [Abstract][Full Text] [Related]
28. Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer.
Liu C; Lv H; Li Q; Fu S; Tan J; Wang C; Wang X; Ma Y
Medicine (Baltimore); 2020 Jul; 99(28):e21190. PubMed ID: 32664162
[TBL] [Abstract][Full Text] [Related]
29. Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach.
Fussey JM; Khan H; Ahsan F; Prashant R; Pettit L
Head Neck; 2017 Dec; 39(12):2567-2572. PubMed ID: 28960722
[TBL] [Abstract][Full Text] [Related]
30. Thyrotropin suppression by thyroid hormone replacement is correlated with thyroxine level normalization in central hypothyroidism.
Shimon I; Cohen O; Lubetsky A; Olchovsky D
Thyroid; 2002 Sep; 12(9):823-7. PubMed ID: 12481949
[TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment.
Tagay S; Herpertz S; Langkafel M; Erim Y; Freudenberg L; Schöpper N; Bockisch A; Senf W; Görges R
Eur J Endocrinol; 2005 Dec; 153(6):755-63. PubMed ID: 16322380
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
[TBL] [Abstract][Full Text] [Related]
33. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
Jonklaas J; Davidson B; Bhagat S; Soldin SJ
JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
[TBL] [Abstract][Full Text] [Related]
34. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
Park S; Kim WG; Han M; Jeon MJ; Kwon H; Kim M; Sung TY; Kim TY; Kim WB; Hong SJ; Shong YK
Thyroid; 2017 Sep; 27(9):1164-1170. PubMed ID: 28699428
[TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.
Klaver EI; van Loon HC; Stienstra R; Links TP; Keers JC; Kema IP; Kobold AC; van der Klauw MM; Wolffenbuttel BH
Thyroid; 2013 Sep; 23(9):1066-73. PubMed ID: 23530992
[TBL] [Abstract][Full Text] [Related]
36. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
[TBL] [Abstract][Full Text] [Related]
37. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
[TBL] [Abstract][Full Text] [Related]
38. Effect of Thyroid-Stimulating Hormone Suppression on Muscle Function After Total Thyroidectomy in Patients With Thyroid Cancer.
Lee JC; Song BS; Kang YM; Kim YR; Kang YE; Lee JH; Shong M; Yi HS
Front Endocrinol (Lausanne); 2021; 12():769074. PubMed ID: 34858341
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
[TBL] [Abstract][Full Text] [Related]
40. Thyroid Hormone Suppression Therapy.
Biondi B; Cooper DS
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):227-237. PubMed ID: 30717904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
